NeuroPace ranked #9 Holder of Pervasive Neurotech Intellectual Property*

by

NeuroPaceNeu­roPace is a pri­vate­ly held com­pa­ny whose main prod­uct is the RNS (respon­sive neu­rostim­u­la­tion) Sys­tem for treat­ment of refrac­to­ry epilep­sy. Respon­sive neu­rostim­u­la­tion is a tech­nique where­by a set of elec­trodes detects the like­ly onset of an epilep­tic episode and applies stim­u­la­tion to the brain to pre­vent the episode. The pri­ma­ry appli­ca­tion of RNS is inva­sive and requires sur­gi­cal implan­ta­tion of the elec­trodes direct­ly on the brain or with­in the brain. How­ev­er, Neu­roPace’s patent port­fo­lio cov­ers both inva­sive tech­niques (ECoG) and non­in­va­sive (EEG, mag­net­ic stimulation).

  • Loca­tion: Moun­tain View, CA
  • Num­ber of employ­ees: <100
  • Per­va­sive neu­rotech US patent grants: 8
  • Per­va­sive neu­rotech US pend­ing appli­ca­tions: 3

*Neu­roPace ranked #9 in Sharp­Brains’ Per­va­sive Neu­rotech IP Strength Index, thanks to patents such as:

  • US6473639: Neu­ro­log­i­cal event detec­tion pro­ce­dure using processed dis­play chan­nel based algo­rithms and devices incor­po­rat­ing these procedures
  • US6353754: Sys­tem for the cre­ation of patient spe­cif­ic tem­plates for epilep­ti­form activ­i­ty detection
  • US6402678: Means and method for the treat­ment of migraine headaches
  • US6230049: Inte­grat­ed sys­tem for EEG mon­i­tor­ing and elec­tri­cal stim­u­la­tion with a mul­ti­plic­i­ty of electrodes

To learn more about Sharp­Brains’ take on the orga­ni­za­tion’s #Per­va­siveNeu­rotech IP port­fo­lio, and over­all data and trends, click on Per­va­sive Neu­rotech­nol­o­gy: A Ground­break­ing Analy­sis of 10,000+ Patent Fil­ings Trans­form­ing Med­i­cine, Health, Enter­tain­ment, and Busi­ness.